Chediak-Higashi Syndrome

This is a rare genetic disorder. It affects the immune system, making people more likely to get infections. It also causes a type of skin and eye problem called albinism. People with this condition often develop blood cancers later in life.

Condition

What people with Chediak-Higashi Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Chediak-Higashi Syndrome?

NameHow it went

About Chediak-Higashi Syndrome

What It Is

Chediak-Higashi syndrome (CHS) is a rare inherited condition that weakens the immune system and affects pigment, blood clotting and, over time, the nervous system. Children with the classic form usually have repeated, often serious bacterial and other infections beginning in infancy or early childhood. Most also have partial albinism: lighter than expected skin, hair and eye color, with hair that often has a metallic sheen. The same pigment changes can cause reduced sharpness of vision, involuntary eye movements (nystagmus) and sensitivity to light. Many people bruise easily and bleed more than usual. The most dangerous feature is a complication called the accelerated phase, also known as hemophagocytic lymphohistiocytosis (HLH). In HLH, immune cells become overactive, multiply and invade organs, causing high fever, bleeding, overwhelming infection and organ failure. It is often thought to be set off by a viral infection and is life-threatening without treatment. CHS is best understood as a range. Some people have a milder, atypical form that is noticed in adolescence or adulthood, with subtler pigment changes and fewer severe infections. Everyone with CHS, whatever the form, remains at risk of HLH and of nerve and brain problems later in life.

Causes & Risk Factors

CHS is caused by changes (variants) in a gene called LYST. This gene helps control how materials move into lysosomes, small compartments that cells use to break down bacteria and waste. When LYST does not work properly, lysosomes and related structures become abnormally large. In immune cells, this keeps them from responding well to germs. In pigment cells, the color-making granules trap pigment instead of spreading it. In platelets, the cell fragments that help blood clot, it contributes to the bleeding tendency, and in nerve cells it likely contributes to later neurologic problems. The condition is inherited in an autosomal recessive pattern, which means a person develops it only when they receive a changed copy of LYST from each parent. Parents who each carry one copy usually have no symptoms. When both parents are carriers, each pregnancy has a 25 percent chance of a child with CHS, a 50 percent chance of a child who is an unaffected carrier, and a 25 percent chance of a child who neither has the condition nor carries it. Nothing a parent did during pregnancy causes CHS.

How It's Diagnosed

CHS is usually suspected in a child with light-colored skin and hair, a metallic hair sheen and repeated serious infections, or in an older person with partial albinism and unexplained nerve problems. The key test is a simple blood smear: under the microscope, white blood cells in CHS contain unusually large granules that are a hallmark of the condition. Genetic testing that finds disease-causing variants in both copies of the LYST gene confirms the diagnosis and makes testing of relatives possible. Once CHS is diagnosed, doctors check for signs of the accelerated phase (HLH) and assess the eyes, bleeding tendency and nervous system. Because early transplant may be possible before HLH develops, brothers and sisters of an affected person, older and younger, should be evaluated as early as possible.

Treatment Options

The only treatment that targets the underlying problem is a hematopoietic stem cell transplant (HSCT), sometimes called a bone marrow transplant. It replaces the person's blood-forming cells with healthy donor cells. A successful transplant can correct the immune and blood problems, including the risk of HLH, which is why earlier transplant, before HLH develops, is a central goal for people with classic CHS. Transplant carries serious risks of its own, and it does not appear to prevent the nerve and brain problems that can appear later, so it is not a complete cure. If HLH develops, it needs urgent treatment by a hematology team to calm the overactive immune response, usually before a transplant can be done. Other care is supportive and coordinated across several specialists. This includes prompt treatment and prevention of infections, eye care and low-vision services, and a plan for managing bleeding with a hematologist. Live vaccines (such as the measles, mumps and rubella and chickenpox vaccines) are generally avoided because of the weakened immune system. Aspirin, ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) are avoided because they make bleeding worse. Neurology, physical therapy, occupational therapy and educational or neuropsychological support help as nerve and learning problems emerge. Regular dental care matters too, since gum disease is common.

What to Expect

The course differs greatly between the classic and atypical forms. Without a transplant, most children with classic CHS eventually develop HLH, which is usually life-threatening. With an early, successful transplant, children no longer face the same infection and HLH risk, though they still need lifelong follow-up. Neurologic problems tend to appear in late adolescence or adulthood, whether or not a person has had a transplant. They can include numbness and weakness in the hands and feet (peripheral neuropathy), clumsiness and problems with balance (ataxia), tremor and slowed movement similar to Parkinson's disease, and learning or thinking difficulties. These usually progress slowly, and therapy and practical supports can help people stay active and independent for longer. Daily life often involves regular visits with several specialists, eye care, careful attention to fevers and bleeding, and planning around school or work. Women with CHS have generally reported uneventful pregnancies, but a plan for managing bleeding during delivery and afterward should be made in advance. Because CHS is so rare, care at a center experienced with inherited immune disorders and transplant is valuable, and genetic counseling can help families understand risks for other children.

When to Seek Help

Ask for an evaluation if a child has unusually light skin and hair with repeated or severe infections, or if an older person with partial albinism develops numbness, weakness, balance problems or tremor. Siblings of someone with CHS should be tested early even if they seem well. For someone with CHS, contact the care team right away about any fever or sign of infection, or bleeding or bruising that is more than usual, since these can signal a serious infection or the start of HLH. Bleeding that is heavy or will not stop with pressure needs emergency medical care. Let the team know about new or worsening nerve symptoms at the next visit, sooner if they change quickly.

Questions to Ask Your Doctor

  1. 1.Is my child a candidate for a stem cell transplant, and what are the realistic benefits and risks at this stage?
  2. 2.Which signs of infection or HLH should send us to you right away, and who do we call after hours?
  3. 3.Which vaccines and medicines, including over-the-counter pain relievers, should we avoid or use?
  4. 4.How will we monitor for nerve and brain problems over the years, even after a transplant?
  5. 5.Should other family members be tested, and what would genetic counseling involve for future pregnancies?

Last reviewed • Oct 2026

Educational content, not medical advice.